Skip to main content
Premium Trial:

Request an Annual Quote

Take it to the Crowd

Anne Wojcicki, co-founder and CEO of 23andMe, spoke at Harvard University about crowdsourcing science, reports The Wall Street Journal's Health Blog. Wojcicki said that relying on the crowd can get researchers answers more quickly. For example, she described 23andMe researchers sending out a survey on family history of cancer to customers in their database with mutations linked to cancer. From that, Wojcicki said the company received more than 12,000 responses in 36 hours. "Being able to do research in a real-time way is the way research needs to be done in the future," she said.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.